Breaking News
Get 40% Off 0
Join +750K new investors every month who copy stock picks from billionaire's portfolios Sign Up Free
Close

Dr Reddy’s Laboratories Ltd (REDY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6,080.25 -14.85    -0.24%
14/06 - Closed. Currency in INR ( Disclaimer )
  • Volume: 3,447
  • Bid/Ask: 6,060.00 / 6,084.45
  • Day's Range: 6,038.45 - 6,114.80
Type:  Equity
Market:  India
ISIN:  INE089A01023 
S/N:  DRREDDY
Dr Reddy’s Laboratories 6,080.25 -14.85 -0.24%

REDY Income Statement

 
Featured here, the Income Statement (earnings report) for Dr Reddy’s Laboratories Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
Advanced Income Statement
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Revenue 70830 72148 68802 67384
Revenue 70830 72148 68802 67384
Other Revenue, Total - - - -
Cost of Revenue, Total 29347 29945 28434 27831
Gross Profit 41483 42203 40368 39553
Total Operating Expenses 56044 54300 52301 50285
Selling/General/Admin. Expenses, Total 20476 20228 18795 17702
Research & Development 6877 5565 5447 4984
Depreciation / Amortization 9561 - - -
Interest Expense (Income) - Net Operating -593 -394 -353 -371
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 1753 -1044 -22 139
Operating Income 12970 17848 16501 17099
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 2552 369 437 735
Other, Net -5598 -778 -3070 -2099
Net Income Before Taxes 16016 18257 19134 18463
Provision for Income Taxes 2946 4468 4334 4438
Net Income After Taxes 13070 13789 14800 14025
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 13070 13789 14800 14025
Total Extraordinary Items - - - -
Net Income 13070 13789 14800 14025
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 13070 13789 14800 14025
Dilution Adjustment 0.349 - - -
Diluted Net Income 13069.65 13789 14800 14025
Diluted Weighted Average Shares 166.82 166.78 166.7 166.53
Diluted EPS Excluding Extraordinary Items 78.35 82.68 88.78 84.22
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 59.36 67.45 66.61 64.55
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

REDY Comments

Write your thoughts about Dr Reddy’s Laboratories Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email